At a glance
Continuing Human Enabling Enhancing Restoring and Sustaining is a federal competitive grant from Air Force -- Research Lab for the science & technology sector. Funding is $2K–$2K. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The following guidance is provided for Federally Funded Research and Dev. The application deadline is August 22, 2044. Apply via the official listing at www.grants.gov.
- Amount
- $2K–$2K
- Deadline
- Aug 22, 2044
- Type
- Competitive
- Status
- Open
About this program
The Air Force Research Laboratory, Human Effectiveness Directorate (AFRL/RH) and the United States Air Force School of Medicine (USAFSAM) CHEERS Multiple Authority Announcement (MAA) is intended to provide a comprehensive strategy for AFRL/RH and USAFSAM's range of Science and Technology (S&T) requirements, allowing for progression from basic research to technology maturation and transition.20 Nov 2025: Amendment 01 - Annual UpdateThe CHEERS Multiple Authority Announcement (MAA) MUST be reviewed in tandem with the solicitations in order to have access to all applicable attachments and instructions. There are three (3) open, 2-step, solicitations currently accepting white papers. Please see below for solicitation numbers.Multiple Authority Announcement (MAA), Notice FA238424S2233: 1. CHEERS MAA Open Period 1 – Broad Agency Announcement (BAA), Solicitation FA238424S2334 2. CHEERS MAA Open Period 2 – Procurement for Experimental Purposes (ARA), Solicitation FA238424S2335 3. CHEERS MAA Open Period 3 - Commercial Solutions Opening (CSO), Solicitation FA238424S2336 (NOTE: THIS CSO IS NOT GRANT-ELIGIBLE)Please reach out if you have any questions regarding the MAA and/or the solicitation(s). Technical questions may be directed to the technical POC’s identified in the announcement/solicitations. General questions may be directed to the CHEERS email org box: AFRL.711HPW.MAA@us.af.mil
Who can apply
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The following guidance is provided for Federally Funded Research and Development Centers (FFRDCs) contemplating submitting a proposal in response to a solicitation, as either a prime or subcontractor. FAR 35.107-1(c)(4) prohibits an FFRDC from competing with any non-FFRDC concern in response to a Federal agency request for proposal for other than the operation of an FFRDC (with exceptions stated in DFARS 235.017-1(c)(4)). There is no regulation prohibiting an FFRDC from responding to a solicitation issued under this MAA. However, the FFRDC's sponsoring agency must first make a determination that the effort being proposed falls within the purpose, mission, general scope of effort, or special competency of the FFRDC, and that determination must be included in the FFRDC's proposal. In addition, AFRL must make a determination that the work proposed would not place the FFRDC in direct competition with domestic private industry. Only after these determinations are made, would a determination be made concerning the FFRDC's eligibility to receive an award. Notice to Foreign-Owned Firms: Such firms are asked to immediately notify the Contracting Officer identified in the solicitation before deciding to respond. Foreign contractors should be award that restrictions might apply which could preclude their participation.
How to apply
Apply through Grants.gov using funding opportunity number FA238424S2233. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) NIH · Up to $6.3M · Nov 15, 2027 Open
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) NIH · See listing · Jul 12, 2027 Open
- Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) NIH · See listing · Sep 25, 2026 Open
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) NIH · Up to $25K · Jun 2, 2027 Open